A review of cannabis for inflammatory bowel disease found evidence of improved UC and CD symptom scores and quality of life, but the lack of standardized preparations and doses prevents establishing treatment criteria.
IBD patients, gastroenterologists, medical cannabis researchers
Symptom improvement reported but no standardized treatment protocol can be established
What the researchers found
Cannabis use was associated with improvement in ulcerative colitis and Crohn's disease symptom scores and quality of life across reviewed studies. THC and CBD showed relevant anti-inflammatory and antioxidant properties. However, no standardization exists for plant variety, route of administration, or dosing.
Why it matters
IBD affects millions worldwide and current treatments often have significant side effects. Understanding whether cannabis compounds could complement existing therapies is clinically relevant.
The numbers in context
No specific pooled effect sizes reported; the review synthesizes findings across multiple studies showing symptom score improvement.
How the study worked
Literature review searching PubMed/Medline, PMC, EMBASE, and Cochrane databases for studies on cannabis effects in ulcerative colitis and Crohn's disease.
What this study cannot tell us
No meta-analysis performed; wide heterogeneity in cannabis preparations studied; many studies have small samples; no standardized treatment protocols exist.
How to read the evidence
Narrative review of heterogeneous studies without meta-analysis; underlying evidence limited by lack of standardization.
When this study was published
Published in 2020.
The bigger picture
Patient interest in cannabis for IBD is high, but the gap between preclinical anti-inflammatory evidence and standardized clinical application remains wide.
Questions still open
- Which cannabinoid ratios and delivery methods are optimal for IBD? Do anti-inflammatory effects translate to mucosal healing or just symptom relief?
Common questions
Can cannabis treat Crohn's disease or ulcerative colitis?
What anti-inflammatory effects does cannabis have for IBD?
Read the original research
Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
International journal of molecular sciences, 21(8)
Citation
Carvalho, Antonelly Cassio Alves de; Souza, Gabriela Achete de; Marqui, Samylla Vaz de; Guiguer, Élen Landgraf; Araújo, Adriano Cressoni; Rubira, Claudio José; Goulart, Ricardo de Alvares; Flato, Uri Adrian Prync; Bueno, Patricia Cincotto Dos Santos; Buchaim, Rogério Leone; Barbalho, Sandra M. (2020). Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.. International journal of molecular sciences, 21(8). https://doi.org/10.3390/ijms21082940
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk